Summary
Definition
History and exam
Key diagnostic factors
- presence of risk factors
Other diagnostic factors
- muscle weakness
- generalised fatigue
- paraesthesia
- muscle cramps
- flaccid muscle paralysis
- bradycardia
- nausea and vomiting
- diarrhoea
- shortness of breath
- chest pain
- palpitations
- extrasystoles
- cardiac pauses
- tachypnoea
- depressed or absent deep tendon reflexes
- hypoactive or absent bowel sounds
Risk factors
- kidney dysfunction
- heart failure
- use of renin-angiotensin-aldosterone system inhibitors (RAASi)
- use of aldosterone antagonists
- use of trimethoprim
- liver disease
- tissue breakdown
- distal renal tubule defects
- diabetes mellitus
- diabetic ketoacidosis
- use of other drugs that cause hyperkalaemia
- increased intake of potassium
- metabolic acidosis
- digoxin (digitalis) toxicity
- primary adrenal insufficiency
- hyperkalaemic periodic paralysis
Diagnostic investigations
1st investigations to order
- serum potassium
- 12-lead ECG
- blood gas
- FBC
- plasma glucose
- renal chemistry
- serum calcium
Investigations to consider
- uric acid and phosphorus
- creatine kinase
- serum digoxin level
- cortisol and aldosterone levels
- 24-hour urine potassium excretion
- plasma and urine potassium and osmolality
- urine pH
- plasma renin activity
Treatment algorithm
acute hyperkalaemia with potentially life-threatening features
acute hyperkalaemia without potentially life-threatening features
chronic hyperkalaemia
Contributors
Authors
Sri G. Yarlagadda, MD
Associate Professor
Kidney Institute
The University of Kansas Medical Center
Kansas City
KS
Disclosures
SGY declares that she has no competing interests.
Peer reviewers
Manish Suneja, MD
Professor
University of Iowa and Carver College of Medicine
University of Iowa Hospitals and Clinics
Iowa City
IA
Disclosures
MD receives royalties from McGraw Hill as editor of DeGowin's Diagnostic Examination.
Annette Alfonzo, MbChB, MRCP, MD
Consultant Nephrologist
Victoria Hospital
Kirkcaldy
Fife
UK
Disclosures
AA declares that she has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Alfonzo A, Harrison A, Baines R, et al; UK Kidney Association (formerly the Renal Association). Clinical practice guidelines: treatment of acute hyperkalaemia in adults. June 2020 [internet publication].Full text
Rafique Z, Peacock F, Armstead T, et al. Hyperkalemia management in the emergency department: an expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct;2(5):e12572.Full text Abstract
Lott C, Truhlář A, Alfonzo A, et al. European Resuscitation Council Guidelines 2021: cardiac arrest in special circumstances. Resuscitation. 2021 Apr;161:152-219.Full text Abstract
Clase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2020 Jan;97(1):42-61.Full text Abstract
Rossignol P, Legrand M, Kosiborod M, et al. Emergency management of severe hyperkalemia: guideline for best practice and opportunities for the future. Pharmacol Res. 2016 Nov;113(pt a):585-91.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Pseudohyperkalaemia
More DifferentialsGuidelines
- Clinical practice guidelines: treatment of acute hyperkalaemia in adults
- Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference
More GuidelinesLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer